盐酸艾司洛尔

目的：探讨盐酸艾司洛尔应用于神经外科开颅术后患者室上性心动过速的有效性和安全性及其对血流动力学的影响。

Objective : To evaluate the efficacy and safety of esmolol hydrochloride in treatment of supraventricular tachyarrhythmia after craniotomy and observe the influence of esmolol on hemodynamics .

在1986年12月美国FDA首次批准美国百特医疗用品公司的盐酸艾司洛尔注射液上市。

The FDA of USA approved the esmolol hydrochloride injection of Baxter Medical Products Company listing in December 1986 .

【结论】静脉注射0.5mg/kg盐酸艾司洛尔治疗颈丛麻醉下甲状腺手术患者的心血管反应安全、有效。

[ Conclusion ] Esmolol is effective and safe on cardiovascular reactions of cervical anesthesia .

结论单次静脉注射1～2mg／kg的盐酸艾司洛尔预防气管插管所致心血管反应安全有效，临床效果和副作用与用药剂量有关。

Conclusion A 1 ~ 2 mg / kg bolus of esmolol is effective and safe for preventing the haemodynamic response to tracheal intubation . The clinical and side-effects are all dose-related .

小剂量盐酸艾司洛尔对颈丛麻醉时心血管反应的治疗作用

Treatment Effect of Esmolol on Cardiovascular Reactions of Cervical Anesthesia

β－受体阻滞剂盐酸艾司洛尔的合成

Improved synthesis of β - blocking agent esmolol hydrochloride

【目的】观察小剂量盐酸艾司洛尔对颈丛麻醉下甲状腺手术患者心血管反应的平抑作用。

[ Objective ] To observe the effect of esmolol on cardiovascular reactions of cervical plexus block .

目的：改进超短效β？受体阻滞剂盐酸艾司洛尔的合成方法。

OBJECTIVE : To study the synthetic method of ultra short acting β adrenergic blocking agent esmolol hydrochloride .

【目的】评价盐酸艾司洛尔预防小儿全麻气管插管与拔管时心血管反应的临床效果。

[ Objective ] To evaluate the efficacy of esmolol to prevent the cardiovascular effects of the children undergoing total intravenous anesthesia and trachea intubation .